D'APRILE, GIANVITO
 Distribuzione geografica
Continente #
NA - Nord America 1.569
EU - Europa 238
AS - Asia 168
AF - Africa 2
SA - Sud America 1
Totale 1.978
Nazione #
US - Stati Uniti d'America 1.563
SE - Svezia 96
CN - Cina 88
SG - Singapore 65
IT - Italia 44
GB - Regno Unito 23
RU - Federazione Russa 22
BE - Belgio 20
FR - Francia 10
IN - India 9
DE - Germania 7
AT - Austria 4
CA - Canada 4
IR - Iran 3
BG - Bulgaria 2
NG - Nigeria 2
NL - Olanda 2
PL - Polonia 2
AL - Albania 1
BS - Bahamas 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NO - Norvegia 1
PT - Portogallo 1
PY - Paraguay 1
Totale 1.978
Città #
Fairfield 254
Chandler 252
Ashburn 154
Woodbridge 129
Seattle 112
Cambridge 100
Houston 96
Wilmington 85
Nyköping 80
Singapore 53
Ann Arbor 47
Beijing 46
Lawrence 25
Roxbury 25
Brussels 20
Ruvo Di Puglia 20
Dearborn 16
Des Moines 16
Inglewood 14
Brooklyn 12
Bari 10
Paris 9
Edinburgh 7
Boardman 6
Los Angeles 6
Pune 6
Hefei 5
London 4
Monmouth Junction 4
Santa Clara 4
Vienna 4
Falls Church 3
Jacksonville 3
Martina Franca 3
San Diego 3
San Mateo 3
Shanghai 3
Amsterdam 2
Augusta 2
Cinisello Balsamo 2
Frankfurt am Main 2
Fuzhou 2
Grafing 2
Hebei 2
Lagos 2
Leawood 2
Linyi 2
Milan 2
Montreal 2
Mumbai 2
Nanjing 2
Prescot 2
Rome 2
Shenyang 2
Sofia 2
Stockholm 2
Washington 2
Almaty 1
Ardabil 1
Asunción 1
Baotou 1
Bend 1
Bishkek 1
Bradford 1
Chicago 1
Forest City 1
Guangzhou 1
Helsinki 1
Hounslow 1
Jerusalem 1
Jinan 1
Kunming 1
Lisbon 1
Madrid 1
Nanning 1
Nassau 1
New Bedfont 1
New Delhi 1
New York 1
Oslo 1
Prague 1
San José 1
Shijiazhuang 1
Sioux Falls 1
Tirana 1
Toronto 1
Trani 1
Warsaw 1
Wenzhou 1
Wuhan 1
Xiamen 1
Yingkou 1
Zhengzhou 1
Totale 1.715
Nome #
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 123
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center 104
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 102
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 97
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 94
How Serious Games for Health Enhance Empowerment Related Patient Education: The Impact of Gender 89
Metastatic gastric cancer in the last two decades: Goals achieved and future promises 87
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 86
Bone metastases in biliary cancers: A multicenter retrospective survey 85
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 84
HER-2 inhibition in gastric and colorectal cancers: Tangible achievements, novel acquisitions and future perspectives 82
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer 81
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 81
null 80
Estimating survival probabilities of advanced gastric cancer patients in the second-line setting: The gastric life nomogram 75
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 75
Molecular classifications of gastric cancers: Novel insights and possible future applications 74
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 73
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 71
Immunotherapy for colorectal cancer: where are we heading? 69
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: A multicenter survey and pooled analysis with published data 62
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors 61
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 59
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158) 57
Il prototipo: Dimensioni e Nuclei tematici per contrastare l’Abbandono scolastico (DNA) 37
Immunotherapy for gastric cancers: emerging role and future perspectives 31
Social, constructivist and informal learning processes: Together on the edge for designing digital game-based learning environments 1
Totale 2.020
Categoria #
all - tutte 9.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020400 0 0 0 0 0 0 60 98 104 49 73 16
2020/2021390 29 18 76 10 12 57 52 22 50 22 38 4
2021/2022227 10 4 7 16 8 16 4 22 13 8 30 89
2022/2023483 52 82 44 45 44 51 10 51 70 5 25 4
2023/2024122 6 25 8 22 13 27 1 5 1 3 2 9
2024/2025157 6 13 36 11 12 76 3 0 0 0 0 0
Totale 2.020